Table 4 Long-term outcomes of the 30 patients with liver metastases from Nasopharyngeal Carcinoma

Median overall survival (mo)

45.2 ± 12.1

14.1 ± 8.6

0.039

 1-y overall survival (%)

85.7

53.3

 3-y overall survival (%)

64.1

26.6

 5-y overall survival (%)

40.2

20.0

Median progression-free survival (mo)

21.2 ± 11.0

4.16 ± 2.8

0.007

 1-y progression-free survival (%)

70.0

27

 3-y progression-free survival (%)

53.0

7

 5-y progression-free survival (%)

18.0

0.0

Progression (case)

11 (73.3%)

15 (100%)

0.330

 Intra-hepatic

1 (6.7%)

13 (86.7%)

 Extra-hepatic

7 (46.7%)

0

 Both intra- and extra-hepatic

3 (20.0%)

2 (13.3%)